India’s CDSCO Drafts Compensation Formula For Clinical Trial Participants
This article was originally published in PharmAsia News
India’s agency for drug standards said it has developed a formula for figuring the compensation pharmaceutical companies must make to injured trial participants or families of those who died as a result of the tests.
You may also be interested in...
Teva received a “package of commercial side-deals” for agreeing to halt generic competition to Cephalon’s Provigil (modafinil) throughout the EU, which it “would not have achieved without committing to staying out of the market,” according to findings by the European Commission.
ASTM International is proposing a new standard that will provide a cleaning agent formula for removing dried blood from stainless steel medical devices.
Executive appointments at MyoKardia, Scancell Holdings and Sutro Biopharma